In accordance with the in vitro findings, HT1080 cells that were incubated with serum samples from RA patients before treatment (V1) increased the levels of secreted CD147 relative to the controls and tofacitinib reduced them (Figure 8A). The gene discussed is BSG; the disease is rheumatoid arthritis.